Drs. Greg Lee, Kat Talcott, and Akshay Thomas join to discuss the May 2022 edition of Retinal Physician, found online at http://www.retinalphysician.com. Topics covered include patient and physician Perceptions of intravitreal injection therapy, retinal vein occlusion Clinical Trials, laser for diabetic retinopathy, and uveitis pearls.
Relevant Financial Disclosures:
Dr. Sridhar is a consultant for Genentech and Regeneron. Dr. Talcott is a consultant for Genentech, Regenxbio, and Zeiss. Dr. Thomas is a consultant for Allergan, Avesis, Bausch and Lomb, and Novartis. Dr. Lee is a consultant for Allergan, Alimera, Apellis, and Eyepoint.
CME Information
Release: May 9, 2022; expires May 9, 2025
Reviewers: D. Wilkin Parke III, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.